Berall v. Teleflex Medical Inc.

CourtCourt of Appeals for the Federal Circuit
DecidedJuly 2, 2026
Docket25-1124
StatusUnpublished

This text of Berall v. Teleflex Medical Inc. (Berall v. Teleflex Medical Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Berall v. Teleflex Medical Inc., (Fed. Cir. 2026).

Opinion

Case: 25-1124 Document: 40 Page: 1 Filed: 07/02/2026

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

JONATHAN BERALL, M.P.H., Plaintiff-Appellant

v.

TELEFLEX MEDICAL INC., Defendant-Appellee ______________________

2025-1124 ______________________

Appeal from the United States District Court for the Eastern District of North Carolina in No. 5:22-cv-00331- FL, Judge Louise Wood Flanagan. ______________________

Decided: July 2, 2026 ______________________

MARCUS EDWARD SERNEL, Kirkland & Ellis LLP, Chi- cago, IL, argued for plaintiff-appellant. Also represented by ERIC DAVID HAYES; PETER JASON EVANGELATOS, New York, NY.

NICHOLAS A. BROWN, Greenberg Traurig LLP, San Francisco, CA, argued for defendant-appellee. Also repre- sented by ELANA ARAJ, SCOTT JOSEPH BORNSTEIN, RICHARD CHARLES PETTUS, New York, NY; JONATHAN WISE, Phila- delphia, PA. Case: 25-1124 Document: 40 Page: 2 Filed: 07/02/2026

______________________

Before DYK, STOLL, and STARK, Circuit Judges. STOLL, Circuit Judge. Dr. Jonathan Berall originally filed a patent infringe- ment suit in the United States District Court for the South- ern District of New York against LMA North America, Inc. for infringing claims 1–15 of U.S. Patent No. 5,827,178. The lawsuit was transferred to the United States District Court for the Eastern District of North Carolina after Te- leflex Medical Incorporated acquired LMA and Dr. Berall amended his complaint to add Teleflex’s products to his suit. The District Court for the Eastern District of North Carolina construed the claim term “mounted on” and then granted Teleflex’s motion for summary judgment of nonin- fringement based on its construction. Dr. Berall appeals the district court’s decision to transfer and summary judg- ment of noninfringement. For the reasons discussed below, we affirm the district court’s decision to transfer the case, adopt its construction of the claim term, and affirm its sum- mary judgment of noninfringement. BACKGROUND I The ’178 patent is titled “Laryngoscope for Use in Tra- chea Intubation” and is directed to “a modification of cur- rent state of the art laryngoscopes such that a scope or camera is mounted on its distal end, preferably at or in the vicinity of the far tip of the laryngoscope blade, . . . [and] [t]he camera is operatively connected to a screen arranged for viewing.” U.S. Patent No. 5,827,178 Title, col. 2 ll. 46– 54. In the patented invention, a “screen can be at- tached . . . to the handle of the laryngoscope above the blade, so that the Professional Intubator’s direct view into the mouth and simultaneous view of the screen can be Case: 25-1124 Document: 40 Page: 3 Filed: 07/02/2026

BERALL v. TELEFLEX MEDICAL INC. 3

achieved with no head movement by the Professional Intu- bator and minimal change in his or her line of vision.” Id. at col. 2 ll. 54–59. As illustrated in Figure 4 below, the laryngoscope in the ’178 patent includes a “camera 26,” which “is mounted on the blade 17” and “is powered by a battery 32 [that is] preferably in the handle 21.” Id. at col. 5 ll. 15–16, ll. 32–33. In addition, a “display means” like “television screen 34 [is] mounted on the handle 21.” Id. at col. 5 ll. 34–35.

Id. Fig. 4. Claims 1 through 5 are illustrative and relevant to the issues on appeal and read: 1. A laryngoscope comprising: a handle and a blade, with the blade having a prox- imal end connected to the handle and a distal end projecting laterally therefrom; camera means mounted on the blade in the vicinity of the distal end for observing a visual field; and Case: 25-1124 Document: 40 Page: 4 Filed: 07/02/2026

display means operatively connected to said cam- era means for displaying the visual field at a pre- selected location. 2. The laryngoscope as claimed in claim 1, further including lighting means for illuminating the vis- ual field. 3. The laryngoscope as claimed in claim 2, further including power supply means for powering said camera means and said display means. 4. The laryngoscope as claimed in claim 3, wherein said power supply means are mounted in the han- dle. 5. The laryngoscope as claimed in claim 1, wherein said display means include a screen mounted on the handle and on which is displayed the visual field observed by the camera means. Id. at col. 6 ll. 6–25 (relevant limitations emphasized). II In 2010, Dr. Berall filed suit in the Southern District of New York alleging that LMA infringed claims 1–15 of the ’178 patent by selling the McGrath Series 5 video laryngo- scope. In 2011, the district court stayed the proceedings pending reexamination of the ’178 patent. In 2013, while the stay was in place, LMA merged with Teleflex, with Te- leflex surviving. The reexaminations of the ’178 patent ended six years later with the U.S. Patent and Trademark Office confirming the patentability of all asserted claims in 2019. LMA filed a statement informing the district court of its acquisition by Teleflex in April 2020. In November 2020, Dr. Berall filed a First Amended Complaint, which did not amend his allegations as to LMA, and LMA filed an answer, which did not contest venue. In December 2020, the district court lifted the stay as to LMA. In January Case: 25-1124 Document: 40 Page: 5 Filed: 07/02/2026

BERALL v. TELEFLEX MEDICAL INC. 5

2021, the district court granted Dr. Berall’s motion to sub- stitute Teleflex for LMA. One month later, in February 2021, Teleflex, as LMA’s successor-in-interest, filed a mo- tion for summary judgment of no infringement based on patent exhaustion of LMA’s accused products, which the district court denied. In November 2021, Dr. Berall filed a Second Amended Complaint that included allegations against Teleflex as an entity separate from its interest in LMA, including that Teleflex infringed the ’178 patent through its distribution of Airtraq laryngoscopes. Teleflex moved to dismiss, arguing venue was improper against it- self in the Southern District of New York. Dr. Berall re- sponded that Teleflex waived its right to contest venue when LMA answered the First Amended Complaint. The district court first found that Teleflex had not waived its right to contest venue because it was not Tele- flex who had answered the First Amended Complaint or sought summary judgment. Rather, it was Teleflex acting on behalf of LMA pursuant to Federal Rule of Civil Proce- dure 25(c). The district court also found that it was not un- til Dr. Berall filed his Second Amended Complaint alleging that Teleflex (separate from its role standing in LMA’s shoes) infringed the ’178 patent through Teleflex’s distri- bution of Airtraq laryngoscopes that Dr. Berall had raised allegations against Teleflex as a defendant separate from LMA. The district court also rejected Dr. Berall’s argu- ment that Teleflex forfeited its venue objection via its liti- gation conduct, explaining that all the conduct Dr. Berall pointed to was from when Teleflex was acting only as LMA’s successor-in-interest. The district court did not view this type of participation “as a tactical wait-and-see bypassing of [Teleflex’s] opportunity to declare its desire for a different forum.” J.A. 9. The district court thus trans- ferred the case to a district in which venue for Teleflex was proper, which was the Eastern District of North Carolina. After the case was transferred, the Eastern District of North Carolina held a Markman hearing. Relevant to this Case: 25-1124 Document: 40 Page: 6 Filed: 07/02/2026

appeal, the district court construed the claim term “mounted on” as “fastened to the exterior of.” J.A. 29. Based on this construction, Teleflex moved for summary judgment of noninfringement by the McGrath Series 5 ac- cused products—which were the only accused products still in suit at the time of summary judgment.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

MBO Laboratories, Inc. v. Becton, Dickinson & Co.
474 F.3d 1323 (Federal Circuit, 2007)
Pc Connector Solutions LLC v. Smartdisk Corp.
406 F.3d 1359 (Federal Circuit, 2005)
Absolute Software, Inc. v. Stealth Signal, Inc.
659 F.3d 1121 (Federal Circuit, 2011)
Thorner v. Sony Computer Entertainment America LLC
669 F.3d 1362 (Federal Circuit, 2012)
Amdocs (Israel) Ltd. v. Openet Telecom, Inc.
761 F.3d 1329 (Federal Circuit, 2014)
Mohsenzadeh v. Lee
790 F.3d 1377 (Federal Circuit, 2015)
Advanced Steel Recovery, LLC v. X-Body Equipment, Inc.
808 F.3d 1313 (Federal Circuit, 2015)
Supernus Pharmaceuticals, Inc. v. Iancu
913 F.3d 1351 (Federal Circuit, 2019)
Sequoia Technology, LLC v. Dell, Inc.
66 F.4th 1317 (Federal Circuit, 2023)
Vlsi Technology LLC v. Intel Corporation
87 F.4th 1332 (Federal Circuit, 2023)
Nexstep, Inc. v. Comcast Cable Communications, LLC
119 F.4th 1355 (Federal Circuit, 2024)

Cite This Page — Counsel Stack

Bluebook (online)
Berall v. Teleflex Medical Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/berall-v-teleflex-medical-inc-cafc-2026.